Pear
Eddie’s background combines deep scientific and business experience in biotechnology. At MIT, Eddie’s doctoral studies focused on the development of non-viral gene therapies. After earning his PhD, he joined an early-stage ocular drug delivery company as a scientist on formulation and process scale-up for two clinical drug products, now FDA-approved. Eddie went on to pursue MBA internships at Roche/Genentech and in VC at NanoDimension, before serving as the Head of Corporate Development at Senti Bio, a Pear portfolio company that leverages synthetic biology for next-generation cell and gene therapies.
At Pear, Eddie leads the firm’s investments in companies specializing in innovative Life Sciences. He loves supporting visionary founders in their missions to transform human health and is passionate about the commercial and clinical translation of cutting-edge Life Sciences technologies.
This person is not in any teams
This person is not in any offices
Pear
2 followers
Supporting great minds to build prominent companies from the ground up. They understand what it means to build something from nothing. That journey defines each of their life stories. They are immigrants, having come to America penniless, but with big ideas. They've been entrepreneurs, determined to build great companies. They know now that success emerges only for those who have endured setbacks and overcome hurdles. They’ve learned from their failures, and they know what it takes to succeed. There are no shortcuts when it comes building something extraordinary. All of this finds expression in their work Their success has been rooted in their ability to find those entrepreneurs before others see their potential. They build the bridge between great ideas and the markets that need them. But that’s not all. Once they are already on their way, they lend support and expertise to help their founders make the next jump.